There is growing awareness that the long-standing unmet need for specific counting of therapeutic tissue stem cells has been and continues to be a significant impediment to progress in stem cell therapy, gene and gene editing therapies (because targeting tissue stem cells is essential for durable one-time treatments), and drug development (because...

The RACER Blueprint is comprised of Five key factors, in addition to manufacturing, that are essential to a good idea making it from an academic achievement to part of a clinician’s armamenterium. They are as important as the scientific and engineering foundations of a TEMP (or other advanced therapy) with respect to full commercialization.

· Real...

My name is Sarah Boermeester, and I’m currently a summer intern at ARMI. I’m a rising junior at Worcester Polytechnic Institute, where I study Biomedical Engineering with a concentration in Tissue Engineering. When I’m not studying I love being outdoors, painting, and being with family and friends. My educational background revolves around...

ASME recently sponsored a briefing on Capitol Hill in partnership with the House Manufacturing Caucus to highlight the challenges facing regenerative medicine. The briefing, titled “Organs on Demand: What’s Stopping Us from Made-to-Order Tissues and Organs,” brought together leaders in the field of regenerative medicine who are working to take this...

Researchers in Carnegie Mellon University's Department of Chemical Engineering are collaborating with leading biotechnology company Genentech, a member of the Roche Group, and LumaCyte, a biotechnology instrumentation company based in Charlottesville, Virginia, to develop an advanced biomanufacturing technology for adventitious agent testing, or...